<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medgen</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская генетика</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Genetics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7998</issn><publisher><publisher-name>Publishing House «Genius Media» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25557/2073-7998.2022.09.4-7</article-id><article-id custom-type="elpub" pub-id-type="custom">medgen-2138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКОЕ СООБЩЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRIEF REPORT</subject></subj-group></article-categories><title-group><article-title>Полиморфизм промоторной области гена рецептора ангиотензина II AGTR1 влияет на течение и исход сепсиса у пациентов с диабетом</article-title><trans-title-group xml:lang="en"><trans-title>Single-nucleotide promoter polymorphism of angiotensin II type 1 receptor gene AGTR1 affects to sepsis course and outcome in patients with diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумаченко</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumachenko</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">a_chumachenko@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Писарев</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Pisarev</surname><given-names>V. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черпаков</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherpakov</surname><given-names>R. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьев</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoriyev</surname><given-names>E. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ общей реаниматологии имени В.А. Неговского, ФГБНУ «Федеральный Научный и клинический центр реаниматологии и реабилитологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, V.A.Negovsky Institute of General Reanimatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ общей реаниматологии имени В.А. Неговского, ФГБНУ «Федеральный Научный и клинический центр реаниматологии и реабилитологии»;  ГБУЗ Городская клиническая больница №15 им. О.М. Филатова Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, V.A.Negovsky Institute of General Reanimatology; O.M. Filatov Moscow Clinical Hospital No 15</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>12</month><year>2022</year></pub-date><volume>21</volume><issue>9</issue><fpage>4</fpage><lpage>7</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чумаченко А.Г., Писарев В.М., Черпаков Р.А., Григорьев Е.К., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Чумаченко А.Г., Писарев В.М., Черпаков Р.А., Григорьев Е.К.</copyright-holder><copyright-holder xml:lang="en">Chumachenko A..., Pisarev V..., Cherpakov R..., Grigoriyev E...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medgen-journal.ru/jour/article/view/2138">https://www.medgen-journal.ru/jour/article/view/2138</self-uri><abstract><p>Дисрегуляция артериального давления вносит значительный вклад в течение и исход сепсиса. Одним из генов, влияющих на состояние сосудистой стенки, эндотелий и тонус артериол, является ген рецептора 1 к ангиотензину II (AGTR1). Поэтому целью нашей работы являлось определение вклада в течение и исход сепсиса генетического полиморфизма AGTR1 rs275651. В исследование были включены пациенты ОРИТ (отделения реанимации и интенсивной терапии), n=286, трех ГКБ (городских клинических больниц) в возрасте 18-92 лет с сепсисом. В общей группе (n=286) септических пациентов наблюдалась разница по частоте развития септического шока в зависимости от генотипа AGTR1 rs275651. У носителей генотипа AGTR1 TT реже развивался септический шок по сравнению с пациентами генотипов AGTR1 AT, AA (60% против 73%, р=0,47, ТМФ (точный метод Фишера), OR=1,8, 95% CI: 1,1-3,3). В подгруппе пациентов с сахарным диабетом второго типа (n=79) были выявлены различия в летальности. Так, носители генотипа TT AGTR1 rs275651 характеризовались меньшим уровнем летальности по сравнению с носителями генотипов ТA, AA (60% против 88%, р=0,018, OR=5,0, 95% CI: 1,34-18,9, ТМФ). Частота развития септического шока у носителей более распространенного генотипа AGTR1 TT также была ниже в подгруппе пациентов с диабетом (57% против 92%; p=0,02, OR=9,2 95% CI: 1,97-42,9, ТМФ). Таким образом, полиморфные варианты промоторной области гена AGTR1 влияют на частоту развития септического шока, а также на течение и исход сепсиса у пациентов с сахарным диабетом.</p></abstract><trans-abstract xml:lang="en"><p>Dysregulation of blood pressure significantly impacts the course and outcome of sepsis. The AGTR1 gene encodes angiotensin II receptor type 1, which affects the vascular tone and contributes to septic shock. Our study aims to define whether the AGTR1 polymorphism contributes to the course and outcome of sepsis. The study included patients (n=286) from three ICU (Intensive Care Unit) aged 18-92 years with sepsis. In all patients (n=286) with sepsis the incidence of septic shock differed depending on AGTR1 genotype: carriers of the AGTR1 TT genotype had a less incidence of septic shock compared with patients with the AGTR1 AT, AA genotypes (60% vs. 73%, P = 0.47, FET (Fisher`s Exact Test), OR=1.8, 95% CI: 1.1-3.3). In group of patients with diabetes mellitus (n=79), we also found differences in sepsis course and outcome based on the AGTR1 rs275651 genotypes. The subgroup of TT AGTR1 rs275651 genotype carriers demonstrated significantly lower mortality compared with TA, AA genotypes carriers (60 % vs. 88 %, Р=0,018, OR=5,0, 95% CI: 1,34 -18,9, FET). The incidence of septic shock was also less in AGTR1 TT genotype-carriers in subgroup patients with diabetes (57% vs 92%, P=0,02, OR=9,2, 95 % CI: 1.97-42.9, FET). We found an association of the functional polymorphism AGTR1 rs275651 with course and outcome of sepsis in ICU patients with diabetes mellitus: carriers of the more common TT genotype had less incidence of septic shock and lower mortality compared to carriers of the minor A allele.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>генетический полиморфизм</kwd><kwd>AGTR1</kwd><kwd>сахарный диабет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>genetic polymorphism</kwd><kwd>AGTR1</kwd><kwd>diabetes</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rivard K., Grandy S. A., Douillette A., Paradis P., Nemer M., Allen B.G., Fiset C. Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart. Am J Physiol Heart Circ Physiol. 2011 Nov; 301(5):H2018-27. doi: 10.1152/ajpheart.01092.2010</mixed-citation><mixed-citation xml:lang="en">Rivard K., Grandy S. A., Douillette A., Paradis P., Nemer M., Allen B.G., Fiset C. Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart. Am J Physiol Heart Circ Physiol. 2011 Nov; 301(5):H2018-27. doi: 10.1152/ajpheart.01092.2010</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dimitrijevic I., Ekelund U., Edvinsson M-L., Edvinsson L. Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome. Heart Vessels. 2009 Nov;24(6):393-8. doi: 10.1007/s00380-008-1136-8</mixed-citation><mixed-citation xml:lang="en">Dimitrijevic I., Ekelund U., Edvinsson M-L., Edvinsson L. Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome. Heart Vessels. 2009 Nov;24(6):393-8. doi: 10.1007/s00380-008-1136-8</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Qian X., Guo D., Zhou H., Qiu J., Wang J., Shen C., Guo Z., Xu Y., Dong C.Interactions Between PPARG and AGTR1 Gene Polymorphisms on the Risk of Hypertension in Chinese Han Population. Genet Test Mol Biomarkers. 2018 Feb;22(2):90-97. doi: 10.1089/gtmb.2017.0141</mixed-citation><mixed-citation xml:lang="en">Qian X., Guo D., Zhou H., Qiu J., Wang J., Shen C., Guo Z., Xu Y., Dong C.Interactions Between PPARG and AGTR1 Gene Polymorphisms on the Risk of Hypertension in Chinese Han Population. Genet Test Mol Biomarkers. 2018 Feb;22(2):90-97. doi: 10.1089/gtmb.2017.0141</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Smyth L.J., Cañadas-Garre M., Cappa R.C., Maxwell A.P., McKnight A.J. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis. BMJ Open. 2019 May 1;9(4):e026777. doi: 10.1136/bmjopen-2018-026777</mixed-citation><mixed-citation xml:lang="en">Smyth L.J., Cañadas-Garre M., Cappa R.C., Maxwell A.P., McKnight A.J. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis. BMJ Open. 2019 May 1;9(4):e026777. doi: 10.1136/bmjopen-2018-026777</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ghafil F.A., Mohammad B.I., Al-Janabi H. S., Hadi N.R., Al-Aubaidy H.A. Genetic Polymorphism of Angiotensin II Type 1 Receptors and Their Effect on the Clinical Outcome of Captopril Treatment in Arab Iraqi Patients with Acute Coronary Syndrome (Mid Euphrates). Indian J Clin Biochem. 2021 Jan;36(1):81-87. doi: 10.1007/s12291-019-00860-x</mixed-citation><mixed-citation xml:lang="en">Ghafil F.A., Mohammad B.I., Al-Janabi H. S., Hadi N.R., Al-Aubaidy H.A. Genetic Polymorphism of Angiotensin II Type 1 Receptors and Their Effect on the Clinical Outcome of Captopril Treatment in Arab Iraqi Patients with Acute Coronary Syndrome (Mid Euphrates). Indian J Clin Biochem. 2021 Jan;36(1):81-87. doi: 10.1007/s12291-019-00860-x</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jin T., Ren Y. ,Zhu X., Li X., Ouyang Y., He X.,Zhang Z., Zhang Y. Kang L., Yuan D. Angiotensin II receptor 1 gene variants are associated with high-altitude pulmonary edema risk. Oncotarget. 2016 Nov 22;7(47):77117-77123.doi: 10.18632/oncotarget.12489</mixed-citation><mixed-citation xml:lang="en">Jin T., Ren Y. ,Zhu X., Li X., Ouyang Y., He X.,Zhang Z., Zhang Y. Kang L., Yuan D. Angiotensin II receptor 1 gene variants are associated with high-altitude pulmonary edema risk. Oncotarget. 2016 Nov 22;7(47):77117-77123.doi: 10.18632/oncotarget.12489</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez-Rodríguez N., Posadas-Romero C., Cardoso G., Perez-Rodriguez J. M., Perez-Hernandez N., Vallejo M., Vargas-Alarcón G. Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals. J Renin Angiotensin Aldosterone Syst.2012 Mar;13(1):133-40. doi: 10.1177/1470320311419175</mixed-citation><mixed-citation xml:lang="en">Martínez-Rodríguez N., Posadas-Romero C., Cardoso G., Perez-Rodriguez J. M., Perez-Hernandez N., Vallejo M., Vargas-Alarcón G. Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals. J Renin Angiotensin Aldosterone Syst.2012 Mar;13(1):133-40. doi: 10.1177/1470320311419175</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mottl A.K., Shoham D.A., North K. E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med. 2008 Aug;10(8):560-74. doi: 10.1097/gim.0b013e3181809613</mixed-citation><mixed-citation xml:lang="en">Mottl A.K., Shoham D.A., North K. E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med. 2008 Aug;10(8):560-74. doi: 10.1097/gim.0b013e3181809613</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nakada T.A., Russell J.A., Boyd J.H., McLaughlin L., Nakada E., Thair S.A., Hirasawa H., Oda S., Walley K.R. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med. 2011 Jul;39(7):1641-8. doi: 10.1097/CCM.0b013e318218665a</mixed-citation><mixed-citation xml:lang="en">Nakada T.A., Russell J.A., Boyd J.H., McLaughlin L., Nakada E., Thair S.A., Hirasawa H., Oda S., Walley K.R. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med. 2011 Jul;39(7):1641-8. doi: 10.1097/CCM.0b013e318218665a</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Чумаченко А.Г., Григорьев Е.К., Писарев В.М. Вклад полиморфизма промоторной области гена AGTR1 в течение и исход сепсиса у пациентов с различной коморбидностью. Общая реаниматология. 2021;17(5):35-51. https://doi.org/10.15360/1813-9779-2021-5-35-51</mixed-citation><mixed-citation xml:lang="en">Чумаченко А.Г., Григорьев Е.К., Писарев В.М. Вклад полиморфизма промоторной области гена AGTR1 в течение и исход сепсиса у пациентов с различной коморбидностью. Общая реаниматология. 2021;17(5):35-51. https://doi.org/10.15360/1813-9779-2021-5-35-51</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Chen X., Huang L., Zhou L. N., Wu G., Chen Y. Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosi. Exp. Ther. Med.2014 May;7(5):1342-1348. doi: 10.3892/etm.2014.1566</mixed-citation><mixed-citation xml:lang="en">Zhang W., Chen X., Huang L., Zhou L. N., Wu G., Chen Y. Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosi. Exp. Ther. Med.2014 May;7(5):1342-1348. doi: 10.3892/etm.2014.1566</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кочкин А.А., Яворовский А.Г., Берикашвили Л.Б., Лихванцев В.В. Современная вазопрессорная терапия септического шока (обзор). Общая реаниматология. 2020;16(2):77-93. https://doi.org/10.15360/1813-9779-2020-2-77-93.</mixed-citation><mixed-citation xml:lang="en">Кочкин А.А., Яворовский А.Г., Берикашвили Л.Б., Лихванцев В.В. Современная вазопрессорная терапия септического шока (обзор). Общая реаниматология. 2020;16(2):77-93. https://doi.org/10.15360/1813-9779-2020-2-77-93.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
